Home Cart Sign in  
Chemical Structure| 40246-10-4 Chemical Structure| 40246-10-4

Structure of Glycitin
CAS No.: 40246-10-4

Chemical Structure| 40246-10-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Glycitin, a natural isoflavone, could promote the proliferation of bone marrow stromal cells and osteoblasts and protect the loss of bone. It can be isolated and purified from legumes.

Synonyms: Glycitein 7-O-β-glucoside; Glycitein-7-β-O-glucoside; ZX-AFC000687

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Glycitin

CAS No. :40246-10-4
Formula : C22H22O10
M.W : 446.40
SMILES Code : O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](OC2=CC(OC=C(C3=CC=C(O)C=C3)C4=O)=C4C=C2OC)[C@@H]1O
Synonyms :
Glycitein 7-O-β-glucoside; Glycitein-7-β-O-glucoside; ZX-AFC000687
MDL No. :MFCD00800711
InChI Key :OZBAVEKZGSOMOJ-MIUGBVLSSA-N
Pubchem ID :187808

Safety of Glycitin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human dermal fibroblasts 10 μM 24 hours Promote proliferation and migration of fibroblasts Exp Mol Med. 2017 Mar 17;49(3):e302
HaCaT keratinocytes 10 μM 24 hours Promote proliferation and migration of keratinocytes Exp Mol Med. 2017 Mar 17;49(3):e302
THP-1 25, 50, 100, 200, 400 μM 48 hours Evaluate the effect of Glycitin on cell viability, results showed concentrations below 50 μM were non-toxic to the cells Cell Biol Toxicol. 2025 Feb 8;41(1):41
H1299 25, 50, 100, 200, 400 μM 48 hours Evaluate the effect of Glycitin on cell viability, results showed concentrations below 50 μM were non-toxic to the cells Cell Biol Toxicol. 2025 Feb 8;41(1):41
A549 25, 50, 100, 200, 400 μM 48 hours Evaluate the effect of Glycitin on cell viability, results showed concentrations below 50 μM were non-toxic to the cells Cell Biol Toxicol. 2025 Feb 8;41(1):41
soybean cotyledon suspension cultures 25.78±1.07 µg/g DW (control), 36.59±0.59 µg/g DW (UV-B treated) 40 µW/cm² UV-B radiation for 2 h, followed by 12 h incubation in the dark UV-B radiation significantly increased Glycitin content in cotyledon suspension cultures Foods. 2024 Jul 28;13(15):2385

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice Excisional wound model Topical administration 200 μM Once daily for 14 days Promote wound closure and reduce scar formation Exp Mol Med. 2017 Mar 17;49(3):e302
Male Wistar rats Pentylenetetrazol (PTZ)-induced seizure model Intraperitoneal injection 5, 10, and 20 mg/kg Once every 48 hours for a total of 21 days To evaluate the anticonvulsant effect of Glycitin on PTZ-induced seizures and its impact on oxidative stress and the Nrf2/HO-1 signaling pathway. Results showed that Glycitin pretreatment effectively mitigated PTZ-induced convulsive behaviors and improved oxidative stress markers (MDA, GPx, and SOD levels), while activating the Nrf2/HO-1 signaling pathway. Front Pharmacol. 2024 Aug 23;15:1392325

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02026518 Irritable Bowel Disease Phase 4 Completed - Iran, Islamic Republic of ... More >> Gastrointestinal Clinics of Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.24mL

0.45mL

0.22mL

11.20mL

2.24mL

1.12mL

22.40mL

4.48mL

2.24mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories